Abstract Mesenchymal Stem Cells (MSCs) have been shown to be a promising candidate for
cell-based therapy. The therapeutic potential of MSCs, towards tissue repair and wound …

The mesenchymal stroma harbors an important population of cells that possess stem cell-
like characteristics including self renewal and differentiation capacities and can be derived …

Mesenchymal stem cells (MSCs) can donate mitochondria and rescue anthracycline-
induced cardiomyocyte (CM) damage, although the underlying mechanisms remain elusive …

Adult stem cell therapies have provided success for more than 50 years, through
reconstitution of the hematopoietic system using bone marrow, umbilical cord blood, and …

We previously found that mesenchymal stem cells (MSCs) derived from human-induced
pluripotent stem cells (iPSCs) exerted immunomodulatory effects on Th2-mediated allergic …

Mesenchymal stem cells (MSCs) are being tested in a wide range of human diseases;
however, loss of potency and inconsistent quality severely limit their use. To overcome these …

The therapeutic potential of mesenchymal stem cell (MSC) transplantation for the treatment
of ischemic conditions such as coronary artery disease, peripheral arterial disease, and …

Current therapies for multiple sclerosis (MS) are largely palliative, not curative.
Mesenchymal stem cells (MSCs) harbor regenerative and immunosuppressive functions …

In extensive bone defects, tissue damage and hypoxia lead to cell death, resulting in slow
and incomplete healing. Human embryonic stem cells (hESC) can give rise to all specialized …

Poor angiogenesis within tissue‐engineered grafts has been identified as a main challenge
limiting the clinical introduction of bone tissue‐engineering (BTE) approaches for the repair …